Frankfurt: AstraZeneca denies its COVID-19 vaccine is not very effective for people over 65, after German media reports said officials feared the shot may not be approved in the European Union for use in the elderly.
German daily papers Handelsblatt and Bild said in separate reports the vaccine – co-developed by AstraZeneca and Oxford University – had an efficacy of 8 per cent or less than 10 per cent, respectively, in those over 65 years of age.
In a written response, AstraZeneca described the German media reports as “completely incorrect”.
It said Britain’s Joint Committee on Vaccination and Immunisation supported the vaccine’s use in the elderly. It also said that a strong immune response to the vaccine had been shown in blood analysis of elderly trial participants.